Two studies aim to slow the onset of Parkinson's disease

| No Comments
Pin It

University of Minnesota researchers have recently published updates to two distinct efforts aimed at combatting Parkinson's disease (PD) by tackling the basic science behind the disease.

The end goal of the two studies is to advance understanding of the mechanism's behind the condition's neurodegeneration in hopes of developing a drug that will provide effective therapy for PD patients, treating the underlying causes of the disease and other related disorders.

Parkinson's disease is a disease of the central nervous system, and 60,000 people in the United States are diagnosed with the condition each year. The most obvious symptom of the disease is uncontrolled body movements when resting. Once the disease progresses further a patient can experience changes in their mood, dementia, problems with their senses and sleep difficulties.

Read more about these two distinct studies.

Leave a comment